BRAF and neoplasm: This metabolic adaptation is generally linked to increased resistance to apoptosis and tumor aggressiveness [52] and it might also be driven by the upregulation of the MAPK signaling pathway in the BRAF-mutant cells [53], such as the A2058 cell line.